3 Great Reasons Why Reckitt Benckiser plc Is Set To Take Off

Royston Wild looks at the major share price drivers for Reckitt Benckiser plc (LON: RB).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at why I believe Reckitt Benckiser (LSE: RB) (NASDAQOTH: RBGLY.US) is an excellent stock selection for savvy investors.

Stellar brands keep revenues rolling

Reckitt Benckiser is home to a multitude of self-proclaimed ‘Powerbrands’ across the household goods space, from detergents and cleaning products such as Finish and Vanish through to pain reliever Nurofen and Strepsils throat lozenges. The popularity of these brands helped push net revenues 7% higher in January-June, to £4.99bn, and adjusted operating profit 3% higher to £1.16bn.

The strength, and consequent pricing clout, of these labels is helping the business to steadily improve margins, and first-half gross margins leapt 230 basis points to 58.7%. These brands are also helping to drive operations in emerging markets, and although break-neck activity in these regions has slowed owing to wider economic considerations, Reckitt Benckiser’s excellent margin story should keep earnings rolling even if consumer spending is squeezed.

Questions rumble over Suboxone rivals

A long-running point of concern for investors has been the loss of Reckitt Benckiser’s patent in the US for its Suboxone tablets and film, which are used to combat drug addiction. This opens the door to rivals treading on the company’s territory, and Orexo is planning to launch its Zubsolv product in mid-September.

Although the introduction of the drug on long-term revenues remains an unknown at this stage, the brand strength and long-standing reputation of Reckitt Benckiser’s product will make it difficult for its competitors to make initial inroads into its market share. And with prescriptions between the drugs not interchangeable, and Reckitt Benckiser maintaining coupon rebates and conducting regular visits to doctors in the States, its rivals may have a tough time claiming revenues from Suboxone.

An excellent all-round for reliable returns

Not many stocks have been able to maintain steady earnings and dividend growth in recent years, but Reckitt Benckiser has chiselled out a way to keep both ticking higher.

The household goods giant has seen earnings per share (EPS) rise over each of the past five years, riding out the effect of wider macroeconomic weakness on consumers’ wallets throughout the period. And following last year’s 7% EPS rise, analysts are expecting a fractional improvement this year to 267.6p before a more marked 3% increase in 2014 to 276.7p.

As well, Reckitt Benckiser has relentlessly lifted the full-year dividend, and 2012’s payment was up more than 67% from that of five years previously, at 134p per share. And City brokers expect this to continue rolling higher, with dividends of 139.3p per share and 146.6p per share forecast for 2013 and 2014 respectively.

Multiply your investment income with the Fool

Although Reckitt Benckiser fails to carry spectacular dividend yields for these years — readouts of 3.2% and 3.3% are in line with the average forward reading of 3.2% for the complete FTSE 100 — I reckon that a backdrop of improving earnings should underpin increasingly-appetising dividends further out.

But whether or not you fancy taking a look at Reckitt Benckiser, I believe that you should check out this brand new and exclusive report which singles out a host of FTSE 100 winners to really jump start your investment income.

Our “5 Dividend Winners To Retire On” wealth report highlights a selection of incredible stocks with an excellent record of providing juicy shareholder returns. Among our picks are top retail, pharmaceutical and utilities plays which we are convinced should continue to provide red-hot dividends. Click here to download the report — it’s 100% free and comes with no further obligation.

> Royston does not own shares in Reckitt Benckiser.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »